Skip to main content
BOWBowhead Specialty Holdings Inc.Buy Wait6.2·$31.11+5.28%
Buy WaitModerate Confidence
Investment thesis

Bowhead Specialty shows strong 27% growth and an attractive valuation backed by a beat streak, but an overbought momentum reading flagged as late-cycle distribution risk and a negative-asymmetry setup after reaching its target temper the near-term upside.

Thesis pillars

  • Strong Growth And Attractive ValuationStable
  • Analyst Target Reached Negative AsymmetryStable
  • Overbought Late Cycle Distribution RiskImproving
  • +2 more pillars — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Bowhead Specialty Holdings Inc. (BOW) Stock Analysis

Range Bound setup · Catalyst-Driven edge

Buy WaitVALUE-TRAP 1/5GrowthModerate Confidence

Financial Services · Insurance - Property & Casualty

Wait for pullback to $28.74. Weak momentum — blocks BUY_NOW at $31.11. Engine's entry $28.74 (support + ATR (held)) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Concentration risk — Counterparty: AmFam (100.0%); Concentration risk — Customer: four brokers (70.3%).

Bowhead Specialty Holdings underwrites commercial specialty property and casualty insurance — casualty, professional liability, healthcare liability, and Baleen Specialty small-business risks — primarily on an excess and surplus lines basis in the U.S. The company wrote $862.8... Read more

$31.11-4.5% A.UpsideScore 6.2/10#12 of 39 Insurance - Property & Casualty
QualityF-score8 / 9FCF yield-2.84%
Entry $28.74(support + ATR (held))Stop $26.43Target $32.17(resistance)A.R:R -0.5:1
Analyst target$34.14+9.7%7 analysts
$32.17our TP
$31.11price
$34.14mean
$30
$38

Wait for pullback to $28.74. Weak momentum — blocks BUY_NOW at $31.11. Engine's entry $28.74 (support + ATR (held)) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Concentration risk — Counterparty: AmFam (100.0%); Concentration risk — Customer: four brokers (70.3%). Chart setup: RSI 47 mid-range, Bollinger mid-band. Mixed signals. Hold existing position. | News modifier +2 (HOLD_IF_HOLDING → STRONG_BUY_WAIT) Score 6.2/10, moderate confidence.

Passes 4/7 gates (clean insider activity, no SEC red flags, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: speculative.

10-K grounded · weekly refresh

About Bowhead Specialty Holdings Inc.

About Bowhead Specialty Holdings Inc.

Bowhead Specialty Holdings wrote $862.8 million in gross written premiums during 2025, up from $695.7 million in 2024, split across four underwriting divisions: Casualty at 63.8%, Professional Liability at 20.2%, Healthcare Liability at 13.5%, and Baleen Specialty at 2.5%. California generated the largest state share at 18.1% of premium, followed by Florida at 11.5% and Texas at 10.2%.

Bowhead earns premium revenue by underwriting complex commercial specialty risks through two models: a craft approach for large, non-standard accounts that generated 97.2% of 2025 gross written premiums, and a digital approach, including the Baleen Specialty unit, for smaller, standardized risks that produced the remaining 2.8%. Because Bowhead's own insurance subsidiary, Bowhead Insurance Company, Inc., lacks an independent A.M. Best rating, policies are issued on paper provided by American Family Insurance subsidiaries under a strategic fronting arrangement, with premiums then ceded back to Bowhead in exchange for a ceding fee starting at 2.75% and stepping up to 3.25% in May 2026 and 5.0% in May 2027. Distribution runs almost entirely through wholesale and retail insurance brokers rather than direct sales, and four of Bowhead's roughly 67 broker relationships accounted for 70.3% of 2025 gross written premiums. Named competitors include Chubb, Travelers, W.R. Berkley, and Kinsale Capital Group in the $95.1 billion U.S. commercial excess and surplus lines market.

Show full overview

Bowhead's ability to write business at all depends on its fronting relationship with AmFam, since Bowhead Insurance Company currently lacks its own A.M. Best financial strength rating and issues policies instead under three AmFam subsidiaries' paper before ceding 100% of that risk back to its own balance sheet. A downgrade or withdrawal of AmFam's current "A" (Excellent) rating, or a decision by AmFam to exit the arrangement, would leave Bowhead needing to find a replacement fronting carrier with comparable financial strength before it could keep writing new and renewal policies. AmFam also beneficially owned approximately 14.3% of Bowhead's common stock as of December 31, 2025, aligning the fronting carrier's economic interest with Bowhead's own performance.

See also: Financial Services · Insurance - Property & Casualty

From Bowhead Specialty Holdings Inc.'s most recent 10-K filing, extracted July 6, 2026.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Tue, Aug 4, 20269d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (3/4)
Positive news sentiment (+0.67)
Attractive valuation
Risks
Concentration risk — Counterparty: AmFam (100.0%)
Concentration risk — Customer: four brokers (70.3%)
Analyst target reached - limited upside remaining

Key Metrics

P/E (TTM)18.0
P/E (Fwd)12.9
Mkt Cap$1.0B
EV/EBITDA12.5
Profit Mgn10.0%
ROE13.7%
Rev Growth26.9%
Beta-0.11
DividendNone
Rating analysts12

Quality Signals

Piotroski F8/9MoatNarrow

Concentration Risks(10-K Item 1A)

  • HIGHcounterpartyAmFam100%
    10-K Item 1A: 'AmFam cedes 100.0% of this risk, along with the premiums to BICI and receives a ceding fee that is 2.75% on net premiums assumed.'
  • HIGHCustomerfour brokers70%
    10-K Item 1A: '70.3%, or $606.6 million, of our gross written premiums were distributed through four of our approximately 67 brokers'
  • HIGHProductCasualty64%
    10-K Item 1: 'Casualty| $| 550,666 | | | 63.8 | %'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 ceiling hit

GatesMomentum 4.2<4.5A.R:R -0.5=NEGATIVEEARNINGS PROXIMITY 9d<=14d (soft)Insider activity: OKNo SEC red flagsSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRange BoundSuitability: Speculative
RSI
47 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $28.17Resistance $32.83

Price Targets

$26
$29
$32
A.Upside-4.5%
A.R:R-0.5:1

Position Sizing

ConvictionMedium conviction
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-4.5% upside)
! NEWS_MOD=+2: HOLD_IF_HOLDING → STRONG_BUY_WAIT
! momentum at 4.2 (below the engine's 4.5 threshold)

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-08-04 (9d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is BOW stock a buy right now?

Wait for pullback to $28.74. Weak momentum — blocks BUY_NOW at $31.11. Engine's entry $28.74 (support + ATR (held)) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Concentration risk — Counterparty: AmFam (100.0%); Concentration risk — Customer: four brokers (70.3%). Chart setup: RSI 47 mid-range, Bollinger mid-band. Mixed signals. Hold existing position. | News modifier +2 (HOLD_IF_HOLDING → STRONG_BUY_WAIT) Target $32.17 (+3.4%), stop $26.43 (−17.7%), A.R:R -0.5:1. Score 6.2/10, moderate confidence.

What is the BOW stock price target?

Take-profit target: $32.17 (-4.5% upside). Target $32.17 (+3.4%), stop $26.43 (−17.7%), A.R:R -0.5:1. Stop-loss: $26.43.

What are the risks of investing in BOW?

Concentration risk — Counterparty: AmFam (100.0%); Concentration risk — Customer: four brokers (70.3%); Analyst target reached - limited upside remaining.

Is BOW overvalued or undervalued?

Bowhead Specialty Holdings Inc. trades at a P/E of 18.0 (forward 12.9). TrendMatrix value score: 7.3/10. Verdict: Buy (Wait for Entry).

What do analysts say about BOW?

12 analysts cover BOW with a consensus score of 3.8/5. Average price target: $34.

What does Bowhead Specialty Holdings Inc. do?Bowhead Specialty Holdings underwrites commercial specialty property and casualty insurance — casualty, professional...

Bowhead Specialty Holdings underwrites commercial specialty property and casualty insurance — casualty, professional liability, healthcare liability, and Baleen Specialty small-business risks — primarily on an excess and surplus lines basis in the U.S. The company wrote $862.8 million in gross written premiums in 2025 through a strategic fronting arrangement with AmFam and roughly 67 wholesale and retail insurance brokers.

Related stocks: SLDE (Slide Insurance Holdings, Inc.) · ASIC (Ategrity Specialty Insurance Co) · PLMR (Palomar Holdings, Inc.) · HRTG (Heritage Insurance Holdings, In) · RLI (RLI Corp.)
Home Stocks BOW

Latest news

Latest News

Yahoo Finance24d agoEarnings
Seeking Alpha2d ago
Dars.gov.et16d ago
Simplywall.st23d ago
Yahoo Finance23d ago
TradingView14d ago
MarketBeat5d agoAnalyst
Hart Energy12d agoLegal
MarketBeat12d agoAnalyst
Marketscreener.com19d agoEarnings
TradingView19d agoAnalyst
Dars.gov.et8d ago
TradingView8d ago
MarketBeat8d ago
Finimize15d agoLegal
Seeking Alpha15d ago
TradingKey15d ago
MSN15d ago
Benzinga5d agoAnalyst
Benzinga10d agoAnalyst
Loading more...